Canadian Food Inspection Agency

Briefing package for the Vice-President, Policy and Programs, of the Canadian Food Inspection Agency as witness before the Standing Committee on Health on December 12, 2024, on the topic of the Supplementary Estimates (B)

Briefing package for the President of the Canadian Food Inspection Agency as witness before the Standing Committee on Agriculture and Agri-Food on November 30, 2023 on the topic of the Supplementary Estimates (B)

Briefing package for the President of the Canadian Food Inspection Agency as witness before the Standing Committee on Health on March 21, 2024 on the topic of the Supplementary Estimates (C)

Briefing package for the Vice President, Policy and Programs, Canadian Food Inspection Agency, as witness before the Standing Committee on Health on March 23, 2023, on the topic of the Supplementary Estimates (C), 2022-23.

Briefing package for the Canadian Food Inspection Agency for the Standing Committee on Health on November 29, 2022 on the topic of the Supplementary Estimates (B), 2022-2023

Briefing package for the President of the Canadian Food Inspection Agency as witness before the Standing Committee on Health on June 8, 2022, on the topic of the Supplementary Estimates (A)

The Open Government Implementation Plan (OGIP) for the Canadian Food Inspection Agency serves to outline the approach which the Agency will undertake to meet the requirements in the Directive on Open Government.

Briefing package for the President of the Canadian Food Inspection Agency as witness before the Standing Committee on Social Affairs, Science and Technology on June 26, 2020 for the Study on the government’s response to the COVID-19 pandemic

Briefing package for the President of the Canadian Food Inspection Agency as witness before the Standing Committee on Government Operations and Estimates on May 22, 2020 on the topic of the Government's Response to the COVID-19 Pandemic

Briefing package for the President of the Canadian Food Inspection Agency as witness before the Standing Committee on Health (HESA) on February 5, 2021 on the topic of COVID-19 – Vaccines Rollout